Grants for Researchers

National Institutes of Health · Up to $200K

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R21 funds exploratory, higher-risk Down syndrome research — feasibility studies, novel methods, or new applications of existing techniques. Awards up to about $200,000.

National Institutes of Health · Amount varies

Open specifically to federally recognized American Indian/Alaska Native tribes, tribal colleges and universities, tribal health programs, and tribal organizations. This NIH R34 planning grant funds preparatory work to develop competitive Native American Research Centers for Health (NARCH) applications. Eligibility is narrow — limited to AI/AN tribal entities; award size follows standard R34 limits.

National Institutes of Health · Amount varies

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R21 funds projects that improve clinical-trial readiness for rare diseases — developing biomarkers and outcome measures, or characterizing a disease's course to enable future trials. Award size follows standard R21 limits.

Defense Health Agency Contracting Activity - DHACA · $750K–$50M

Open broadly to any type of entity — universities, nonprofits, businesses (including small businesses), and others. This Department of Defense / Defense Health Agency broad agency announcement funds extramural biomedical and human-performance research and development through FY28. Awards span a very wide range, from about $750,000 to $50 million.

National Institutes of Health · Up to $3M

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH UG3/UH3 funds discovery and development of interventions — medications and devices — to prevent and treat substance use disorders and overdose, including preclinical and clinical studies. Awards up to about $3,000,000.

National Institutes of Health · Up to $500K

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 funds development of non-invasive or minimally invasive technologies to image the human olfactory system at high resolution. Awards up to about $500,000; multidisciplinary teams are encouraged.

National Institutes of Health · Amount varies

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.

National Institutes of Health · Amount varies

For existing NCI early-stage-investigator MERIT (R37) awardees applying to extend their award, submitted through their U.S. or eligible institution. The extension provides up to seven years of total support across two segments, giving early-career cancer researchers extra time before a renewal. Eligibility is narrow — limited to current ESI MERIT grantees.

National Institutes of Health · Amount varies

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH/NCI R21 funds early-stage, exploratory research on cancer control — prevention behaviors, screening, etiology, and novel methods. Award size follows standard R21 limits.

National Institutes of Health · Amount varies

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH DP1 (Avant-Garde/Avenir) funds high-risk, high-reward research on HIV and substance use — basic, clinical, translational, or implementation science. It backs bold, transformative ideas; award size follows the DP1 mechanism.

National Institutes of Health · Amount varies

This NIH/NCI P30 Cancer Center Support Grant funds NCI-designated Cancer Centers to integrate their cancer research into a coordinated enterprise. Eligibility is highly restrictive: applicant institutions must already have a large cancer-focused NIH funding base (for example, $6M or $10M in annual direct costs depending on center type). Foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible or allowed.

National Institutes of Health · Up to $1.8M

This NIH/NIEHS P42 grant funds Superfund Research Program Centers that combine biomedical and environmental science and engineering to study hazardous substances. By law, eligibility is limited to accredited institutions of higher education, though they may subcontract with other organizations and governments. Awards are large (up to roughly $1.75M), and foreign organizations and foreign components of U.S. organizations are not eligible to apply.

National Institutes of Health · Amount varies

This NIH/ORIP P40 grant funds Animal and Biological Material Resource Centers that maintain specialized animal colonies, cell and tissue cultures, genetic stocks, and related services for the biomedical research community. Proposed centers must have broad relevance across multiple NIH Institutes. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and foreign components are not allowed.

National Institutes of Health · Amount varies

This NIH/ORIP R24 grant funds research organizations to develop, characterize, or improve models of human health and disease (including new approach methodologies) that are broadly useful across two or more NIH Institutes. Projects narrowly tied to a single disease or to one Institute's interests will not be accepted. Foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible or allowed.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative U24 grant funds organizations to disseminate and integrate existing neuroscience research resources (tools, reagents, training, and access to platforms) into the broader research community. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and applications involving funded foreign subawards/subcontracts will be rejected. Applicants are typically established research institutions with an existing resource to share.

National Institutes of Health · Up to $200K

This NIH R21 grant funds secondary analyses that use archived HIV/AIDS data sets and specimen collections to answer questions about maternal, pediatric, and adolescent HIV/AIDS. Both U.S. and foreign organizations are eligible to apply, but foreign components within a project are not allowed. The award ceiling is up to about $200,000.

Centers for Disease Control and Prevention - ERA · $4.5M–$9M

This CDC/NIOSH program funds academic institutions to run Education and Research Centers providing interdisciplinary training and research in occupational safety and health. Awards are large (roughly $4.5M to $9M). Eligibility is narrow: only one application per institution is allowed, and current holders of a NIOSH T03 training grant cannot receive an award or sub-award under this opportunity.

Centers for Disease Control and Prevention - ERA · $50K–$550K

This CDC/NIOSH T03 program funds Training Project Grants for occupational safety and health education, mostly at academic institutions providing undergraduate, graduate, and post-graduate training, plus a limited number of non-academic awards for specialized audiences. Awards range from roughly $50,000 up to about $550,000. Foreign organizations are not eligible to apply.

National Institutes of Health · Amount varies

This NIH/NHLBI U24 cooperative agreement funds a Data Coordinating Center to provide data management, biostatistics, and project coordination for investigator-initiated multi-site clinical trials. A companion Clinical Coordinating Center application must be submitted on the same due date for consideration. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.

National Institutes of Health · Amount varies

This NIH/NHLBI R61/R33 cooperative agreement funds investigator-initiated single-site clinical trials relevant to the NHLBI mission, using a milestone-driven, two-phase structure. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. Applicants are encouraged to include expertise in biostatistics and clinical trial design.